Introduction: Heart failure (HF) is a serious pathology whose evolution is made of episodes of acute decompensation, rhythmic and thromboembolic complications, causes of iterative hospitalizations and death. The objective of this study was to describe the outcomes of patients followed for heart failure in a cardiological setting in Parakou from 2016 to 2020. Methods: This was a longitudinal, descriptive and analytical retrospective study of heart failure patients followed in consultation and/or hospitalization over a period of 5 years (October 2016 to July 2020) in cardiology units of Parakou. The outcome of HF was assessed by the NYHA symptomatic stage, rehospitalization, complications and death. Epidata 3.1 fr and SPSS 21 software were used for data processing and analysis. Results: Of the 4902 cardiovascular admissions, 453 cases of HF (9.24%) were observed. At the onset of care, 51.50% of patients were at NYHA stage IV and 69.46% had left ventricular systolic dysfunction. During the follow-up period, there was a symptomatic improvement in the first 06 months but at one year of follow-up, 45.28% of the subjects were seen with a deteriorated stage. At one year of follow-up, the rehospitalization rate was 23.58%. The complications noted were arrhythmias in 8.32% of cases. The mortality rate was 30.37%. Advanced age > 60 years, Charlson score ≥ 3, hypokalemia and poor adherence to treatment were the factors associated with unfavorable outcomes. Conclusion: HF is associated with significant morbidity and mortality. This highlights the importance of its prevention, its better etiological research and patient's therapeutic education.
Background: High blood pressure (HBP) is often revealed by cardiovascular event, issue of undiagnosed silent complications. This study aimed at determining the prevalence of chronic complications of HBP among patients followed in cardiology at Parakou in 2016. Methods: We performed a cross sectional analytic study from March 20 th to July 20 th , 2016 in the cardiology settings of Parakou. We did a systematic recruitment of all hypertensive patients who have done the hypertension minimum check up of
Introduction: Heart failure is one of peripartum complications which contribute to maternal mortality. But the epidemiological features of this disease are not well known in Benin. This paper aims at studying the prevalence and associated factors of heart failure during pregnancy and the postpartum in Parakou in 2015. Methods: It was a descriptive and analytic cross sectional study scheduled from March to July 2015. We recruited systematically all pregnant or parturient women, met in Parakou’s hospitals. The inclusion criteria were the presence of at least one cardiovascular symptom. Diagnosis of heart failure was made by using the guidelines of the European Society of Cardiology and of the American Society of Echocardiography. Results: During the survey, 2503 pregnant or parturient women were admitted and 25 (0,99%) were diagnosed with heart failure. Dyspnea was the main symptom (96%). Heart failure was caused by peripartum cardiomyopathy(84%), hypertensive cardiomyopathy (12%) and rheumatic heart disease (4%). Heart failure was more prevalent in patients with the following conditions: age≥30years (p=0,001), low socioeconomic level (p=0,02), multigestational status (p=0,002) and multiparity (p<0,001). The management of heart failure was classic. The main difficulty noted was financial problems with 36% of patients unable to afford the treatment. No case of death was counted during the study. Conclusion: In Parakou, heart failure occurs mostly during the post partum period. Dyspnea was the main symptom. The main etiology was peripartum cardiomyopathy. The associated conditions were age≥30years, low socioeconomic level, multigestational status and multiparity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.